In the context of muscle atrophy in cancer cachexia, two muscle-specific E3 ubiquitin ligases, atrogin-1/MAFbx and muscle ring finger protein 1 (MuRF-1), play pivotal roles in driving muscle proteolysis and wastage. Here, TRIM63 is linked to cancer.